Medtronic launches new diabetes tech integrated with Abbott sensor
Medtronic has announced the U.S. launch of its MiniMed 780G system integrated with sensors manufactured by Abbott. This represents a major step forward for a partnership the two vendors announced in 2024.
The MiniMed 780G is one of the trademark pieces of Medtronic’s diabetes portfolio. It can work with multiple sensors to bring continuous glucose monitoring (CGM) to a wide variety of diabetes patients. The system’s integration with Abbott’s new Instinct sensors gained U.S. Food and Drug Administration approval in September. This represents the first time they have been made available to patients with type 1 diabetes.
“This milestone marks an important next step in our work to bring the proven clinical outcomes of our MiniMed 780G system to more people living with diabetes,” Que Dallara, executive vice president and president of Medtronic’s diabetes division, said in a statement. “With this launch, we're expanding a smart dosing ecosystem built for choice, so every person can find a solution that fits their life. We exist to make life with diabetes easier and more predictable, so people living with diabetes can enjoy greater freedom and better health every day. Our goal is to deliver confidence and peace of mind, so everyone—including loved ones—can live boldly without compromise.”
Abbott has been known for its ultralight CGM sensors for years, primarily the company’s variety of Freestyle Libre sensors. These new Instinct sensors are just 0.11 in x 0.83 in and can be worn for 15 days. They have been approved for any patients with type 1 diabetes seven years old or older. The system automates insulin adjustments every five minutes, and the Instinct sensor's warm-up period of one hour is faster than any other sensors compatible with the MiniMed 780G system.
These systems are now being shipped to U.S. patients.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.